Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

Notch signal reception is required in vascular smooth muscle cells for ductus arteriosus closure.

Krebs LT, Norton CR, Gridley T.

Genesis. 2016 Feb;54(2):86-90. doi: 10.1002/dvg.22916. Epub 2016 Jan 17.

2.

Endoglin is required in Pax3-derived cells for embryonic blood vessel formation.

Young K, Krebs LT, Tweedie E, Conley B, Mancini M, Arthur HM, Liaw L, Gridley T, Vary C.

Dev Biol. 2016 Jan 1;409(1):95-105. doi: 10.1016/j.ydbio.2015.10.019. Epub 2015 Oct 19.

3.

Absence of a major role for the snai1 and snai3 genes in regulating skeletal muscle regeneration in mice.

Norton CR, Chen Y, Han XH, Bradley CK, Krebs LT, Yoon JK, Gridley T.

PLoS Curr. 2013 Nov 8;5. pii: ecurrents.md.e495b27ee347fd3870a8316d4786fc17. doi: 10.1371/currents.md.e495b27ee347fd3870a8316d4786fc17.

4.

The snail family gene snai3 is not essential for embryogenesis in mice.

Bradley CK, Norton CR, Chen Y, Han X, Booth CJ, Yoon JK, Krebs LT, Gridley T.

PLoS One. 2013 Jun 6;8(6):e65344. doi: 10.1371/journal.pone.0065344. Print 2013.

5.

The Notch-regulated ankyrin repeat protein is required for proper anterior-posterior somite patterning in mice.

Krebs LT, Bradley CK, Norton CR, Xu J, Oram KF, Starling C, Deftos ML, Bevan MJ, Gridley T.

Genesis. 2012 Apr;50(4):366-74. doi: 10.1002/dvg.20813. Epub 2012 Jan 5.

6.

Patent ductus arteriosus in mice with smooth muscle-specific Jag1 deletion.

Feng X, Krebs LT, Gridley T.

Development. 2010 Dec;137(24):4191-9. doi: 10.1242/dev.052043. Epub 2010 Nov 10.

7.

Generation of mice with a conditional null allele of the Jagged2 gene.

Xu J, Krebs LT, Gridley T.

Genesis. 2010 Jun;48(6):390-3. doi: 10.1002/dvg.20626.

8.

Notch1 activation in mice causes arteriovenous malformations phenocopied by ephrinB2 and EphB4 mutants.

Krebs LT, Starling C, Chervonsky AV, Gridley T.

Genesis. 2010 Mar;48(3):146-50. doi: 10.1002/dvg.20599.

9.

Notch3 is required for arterial identity and maturation of vascular smooth muscle cells.

Domenga V, Fardoux P, Lacombe P, Monet M, Maciazek J, Krebs LT, Klonjkowski B, Berrou E, Mericskay M, Li Z, Tournier-Lasserve E, Gridley T, Joutel A.

Genes Dev. 2004 Nov 15;18(22):2730-5.

10.

Haploinsufficient lethality and formation of arteriovenous malformations in Notch pathway mutants.

Krebs LT, Shutter JR, Tanigaki K, Honjo T, Stark KL, Gridley T.

Genes Dev. 2004 Oct 15;18(20):2469-73. Epub 2004 Oct 1.

11.

Characterization of Notch3-deficient mice: normal embryonic development and absence of genetic interactions with a Notch1 mutation.

Krebs LT, Xue Y, Norton CR, Sundberg JP, Beatus P, Lendahl U, Joutel A, Gridley T.

Genesis. 2003 Nov;37(3):139-43.

PMID:
14595837
12.

Notch signaling regulates left-right asymmetry determination by inducing Nodal expression.

Krebs LT, Iwai N, Nonaka S, Welsh IC, Lan Y, Jiang R, Saijoh Y, O'Brien TP, Hamada H, Gridley T.

Genes Dev. 2003 May 15;17(10):1207-12. Epub 2003 May 2.

13.
14.

Notch signaling is essential for vascular morphogenesis in mice.

Krebs LT, Xue Y, Norton CR, Shutter JR, Maguire M, Sundberg JP, Gallahan D, Closson V, Kitajewski J, Callahan R, Smith GH, Stark KL, Gridley T.

Genes Dev. 2000 Jun 1;14(11):1343-52.

15.

A novel angiotensin analog with subnanomolar affinity for angiotensin-converting enzyme.

Krebs LT, Hanesworth JM, Sardinia MF, Speth RC, Wright JW, Harding JW.

J Pharmacol Exp Ther. 2000 Apr;293(1):260-7.

PMID:
10734177
16.

Autoradiographic identification of kidney angiotensin IV binding sites and angiotensin IV-induced renal cortical blood flow changes in rats.

Coleman JK, Krebs LT, Hamilton TA, Ong B, Lawrence KA, Sardinia MF, Harding JW, Wright JW.

Peptides. 1998;19(2):269-77.

PMID:
9493859
17.

Angiotensin IV AT4-receptor system in the rat kidney.

Handa RK, Krebs LT, Harding JW, Handa SE.

Am J Physiol. 1998 Feb;274(2 Pt 2):F290-9.

PMID:
9486224
18.

Characterization of the binding properties and physiological action of divalinal-angiotensin IV, a putative AT4 receptor antagonist.

Krebs LT, Kramár EA, Hanesworth JM, Sardinia MF, Ball AE, Wright JW, Harding JW.

Regul Pept. 1996 Dec 3;67(2):123-30.

PMID:
8958583
19.
20.

The angiotensin IV system: functional implications.

Wright JW, Krebs LT, Stobb JW, Harding JW.

Front Neuroendocrinol. 1995 Jan;16(1):23-52. Review.

PMID:
7768321
21.

AT4 receptors: specificity and distribution.

Harding JW, Wright JW, Swanson GN, Hanesworth JM, Krebs LT.

Kidney Int. 1994 Dec;46(6):1510-2.

22.

AT4 receptor binding characteristics: D-amino acid- and glycine-substituted peptides.

Sardinia MF, Hanesworth JM, Krebs LT, Harding JW.

Peptides. 1993 Sep-Oct;14(5):949-54.

PMID:
8284271
23.

Elucidation of a specific binding site for angiotensin II(3-8), angiotensin IV, in mammalian heart membranes.

Hanesworth JM, Sardinia MF, Krebs LT, Hall KL, Harding JW.

J Pharmacol Exp Ther. 1993 Aug;266(2):1036-42.

PMID:
8355180

Supplemental Content

Loading ...
Support Center